Figures & data
Figure 1 Scanning electron micrograph of RGD-ACM liposomes.
Abbreviations: ACM, aclacinomycin A; RGD, arginine-glycine-aspartic acid.
![Figure 1 Scanning electron micrograph of RGD-ACM liposomes.](/cms/asset/a0723fa2-6d4f-43be-b088-43e5fca42ac6/dddt_a_12188176_f0001_b.jpg)
Figure 2 In vitro release of ACM-loaded liposomes in phosphate-buffered saline (pH 7.4, n=3).
Abbreviations: ACM, aclacinomycin A; RGD, arginine-glycine-aspartic acid.
![Figure 2 In vitro release of ACM-loaded liposomes in phosphate-buffered saline (pH 7.4, n=3).](/cms/asset/6e266e16-b926-48f4-b6f6-86b216d88b5a/dddt_a_12188176_f0002_c.jpg)
Figure 3 The sample did not aggregate and still had the appearance of a milky white colloidal solution after being dissolved in phosphate-buffered saline (pH 7.4) and kept at 4°C for (A) one month and (B) two months.
![Figure 3 The sample did not aggregate and still had the appearance of a milky white colloidal solution after being dissolved in phosphate-buffered saline (pH 7.4) and kept at 4°C for (A) one month and (B) two months.](/cms/asset/801c24bc-7ab8-467d-9276-4fe4cd60bdb2/dddt_a_12188176_f0003_c.jpg)
Table 1 Pharmacokinetic parameters of the two formulations
Figure 4 Mean plasma ACM concentration in rats after intravenous administration (8 mg/kg) of the two formulations (n=6). The blue line indicates RGD-ACM liposomes and the red line indicates ACM liposomes.
![Figure 4 Mean plasma ACM concentration in rats after intravenous administration (8 mg/kg) of the two formulations (n=6). The blue line indicates RGD-ACM liposomes and the red line indicates ACM liposomes.](/cms/asset/8aca0c48-691f-4d90-8189-56be201fcc0f/dddt_a_12188176_f0004_c.jpg)
Table 2 Effect of RGD-ACM liposomes and ACM liposomes on A549 cells in nude mice